UOIF II

Mind Foundry

Spun-out of the University of Oxford Machine Learning Group, Mind Foundry has developed advanced machine learning algorithms to help organisations solve problems by unlocking insights hidden deep within their big data.
The day-to-day operation of successful organisations and businesses is increasingly reliant on the analysis of data. Driving these advances is a deluge of data, which is outstripping the […]

Zegami

, , ,

Spun-out of the University of Oxford Computational Biology Research Group in February 2016, Zegami allows users to view large collections of images and associated metadata in a single field of view and to perform intuitive data analysis.

With the ability to display tens of thousands of images, documents, video, 3D objects and dashboards in a single […]

Oxford Endovascular

Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of […]

Animal Dynamics

Animal Dynamics, a spin-out from the Department of Zoology at the University of Oxford, is developing a portfolio of products derived from research into evolutionary adaptations in flight, swimming, walking, and stealth, where nature has arrived at significant performance optimizations which can be applied to commercial products.

Bodle Technologies

,

Bodle Technologies, from the University of Oxford, has developed a novel, smart material for use in low-energy high-resolution displays and glazing. Bodle’s display device offerings offer high flexibility, ultra-high resolution, and very low energy consumption, making a highly attractive proposition for the global display market.

Xerion

Xerion Healthcare seeks to commercialise Dr Helen Townley’s Research Group’s work into the use of nano-particles in cancer for therapy, imaging and drug delivery.

The small size of nano-particles means they can passively accumulate in tumours due to the enhanced permeation and retention (EPR) effect, where certain sizes of molecules accumulate more in tumour cells […]

Orthox

, , ,

Orthox is a medical device company founded to exploit FibroFix, a novel silk-based biomaterial platform, for the repair of injuries to cartilage and bone. FibroFix combines exceptional strength and resilience with a porous architecture and chemical structure similar to Fibronectin, an essential component of human cartilage. Orthox believes these properties will allow FibroFix™ to […]